From: Prevention and control of non-communicable diseases in iran: the case for Investment
5 years | 15 years | |||||
---|---|---|---|---|---|---|
Intervention package | Total costsa | Total benefitsa | ROI | Total costsa | Total benefitsa | ROI |
Policy interventions | ||||||
Tobacco | 5.10 | 45.03 | 8.83 | 12.52 | 176.48 | 14.09 |
Physical inactivity | 0.93 | 31.13 | 33.47 | 2.57 | 119.68 | 46.56 |
Salt | 1.74 | 31.13 | 17.89 | 4.22 | 119.68 | 28.36 |
Clinical interventions | ||||||
CVD and Diabetes | 137.42 | 31.55 | .23 | 490.79 | 126.36 | 0.26 |
Total | 145.17 | 138.86 | 0.95 | 510.1 | 542.22 | 1.06 |
The results for sensitivity analysis of the ROIs | ||||||
5 years | 15 years | |||||
Intervention package | Median ROI (2.5th and 97.5th percentiles) | Median ROI (2.5th and 97.5th percentiles) | ||||
Tobacco | 8.79 (3.43—23.40) | 14.12 (5.36—36.71) | ||||
Physical inactivity | 33.44 (12.44—91.30) | 47.89 (17.75—128.32) | ||||
Salt | 18.18 (6.72—46.46) | 28.71 (10.72—71.34) | ||||
Clinical interventions | ||||||
CVD and Diabetes | 0.23 (0.09—0.58) | 0.26 (0.10—0.64) | ||||
Total | 0.99 (0.49—2.08) | 1.09 (0.57—2.18) |